Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
44
CVS Quote, Financials, Valuation and Earnings
Last price:
$70.10
Seasonality move
:
2.68%
Day range:
$69.67 - $71.43
52-week range:
$58.35 - $85.15
Dividend yield:
3.8%
P/E ratio:
50.65x
P/S ratio:
0.22x
P/B ratio:
1.19x
Volume:
6.1M
Avg. volume:
7.8M
1-year change:
3.68%
Market cap:
$89.2B
Revenue:
$402.1B
EPS (TTM):
$1.38
Analysts' Opinion
-
Consensus RatingCVS Health Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 18 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $96.50, CVS Health Corp. has an estimated upside of 37.7% from its current price of $70.08.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $79.00 representing 100% downside risk from its current price of $70.08.
Fair Value
-
According to the consensus of 22 analysts, CVS Health Corp. has 37.7% upside to fair value with a price target of $96.50 per share.
CVS vs. S&P 500
-
Over the past 5 trading days, CVS Health Corp. has overperformed the S&P 500 by 0.16% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
CVS Health Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CVS Health Corp. has grown year-over-year revenues for 51 quarters straight. In the most recent quarter CVS Health Corp. reported revenues of $105.7B.
Earnings Growth
-
CVS Health Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter CVS Health Corp. reported earnings per share of $2.30.
Enterprise value:
158.6B
EV / Invested capital:
--
Price / LTM sales:
0.22x
EV / EBIT:
12.53x
EV / Revenue:
0.39x
PEG ratio (5yr expected):
0.07x
EV / Free cash flow:
20.32x
Price / Operating cash flow:
11.40x
Enterprise value / EBITDA:
9.18x
Gross Profit (TTM):
$55.4B
Return On Assets:
0.67%
Net Income Margin (TTM):
0.43%
Return On Equity:
2.28%
Return On Invested Capital:
1.1%
Operating Margin:
2.19%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $358.3B | $372.7B | $402.1B | $97.5B | $105.7B | |
| Gross Profit | $54.9B | $51.3B | $55.4B | $12.7B | $13.6B | |
| Operating Income | $15.6B | $9.9B | $12.7B | $2.2B | $2.3B | |
| EBITDA | $19.9B | $14.5B | $17.3B | $3.4B | $3.5B | |
| Diluted EPS | $6.47 | $3.66 | $1.38 | $1.30 | $2.30 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $60B | $65.6B | $67.9B | $68.6B | $74.7B | |
| Total Assets | $240.5B | $236.1B | $257.7B | $260.8B | $261.1B | |
| Current Liabilities | $67.8B | $69.4B | $79.2B | $84.6B | $88.7B | |
| Total Liabilities | $165.1B | $164.4B | $181.1B | $185.1B | $185.7B | |
| Total Equity | $75.4B | $71.8B | $76.6B | $75.7B | $75.4B | |
| Total Debt | $74.4B | $69.1B | $77.4B | $79.1B | $78.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $13.4B | $9.1B | $10.6B | $1.9B | $3.4B | |
| Cash From Investing | -$20.9B | -$7.6B | -$5.9B | -$547M | -$2B | |
| Cash From Financing | $2.7B | -$1.1B | -$4.9B | $431M | -$2B | |
| Free Cash Flow | $10.4B | $6.3B | $7.8B | $1.1B | $2.6B | |
CVS
Sector
Market Cap
$89.2B
$24.6M
Price % of 52-Week High
82.3%
45.36%
Dividend Yield
3.8%
0%
Shareholder Yield
3.51%
-1.84%
1-Year Price Total Return
3.68%
-22.22%
Beta (5-Year)
0.492
0.495
Dividend yield:
3.8%
Annualized payout:
$2.66
Payout ratio:
28.86%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$71.74
200-day SMA
Sell
Level
$74.31
Bollinger Bands (100)
Sell
Level
75.01 - 80.43
Chaikin Money Flow
Buy
Level
1.4B
20-day SMA
Sell
Level
$75.32
Relative Strength Index (RSI14)
Sell
Level
31.68
ADX Line
Sell
Level
24.26
Williams %R
Buy
Level
-95.4846
50-day SMA
Sell
Level
$76.70
MACD (12, 26)
Sell
Level
-1.81
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
295.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2877)
Sell
CA Score
(Annual)
Level (-0.6133)
Buy
Beneish M-Score
(Annual)
Level (-2.571)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (0.6081)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Stock Forecast FAQ
In the current month, CVS has received 18 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CVS average analyst price target in the past 3 months is $96.50.
-
Where Will CVS Health Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CVS Health Corp. share price will rise to $96.50 per share over the next 12 months.
-
What Do Analysts Say About CVS Health Corp.?
Analysts are divided on their view about CVS Health Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CVS Health Corp. is a Sell and believe this share price will drop from its current level to $79.00.
-
What Is CVS Health Corp.'s Price Target?
The price target for CVS Health Corp. over the next 1-year time period is forecast to be $96.50 according to 22 Wall Street analysts, 18 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is CVS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CVS Health Corp. is a Buy. 18 of 22 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CVS?
You can purchase shares of CVS Health Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CVS Health Corp. shares.
-
What Is The CVS Health Corp. Share Price Today?
CVS Health Corp. was last trading at $70.10 per share. This represents the most recent stock quote for CVS Health Corp.. Yesterday, CVS Health Corp. closed at $70.08 per share.
-
How To Buy CVS Health Corp. Stock Online?
In order to purchase CVS Health Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CVS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CVS
Sector
P/E ratio
50.65x
21.03x
PEG ratio
0.07x
-0.01x
P/B ratio
1.19x
1.70x
Price / LTM sales
0.22x
1.45x
Growth Metrics
CVS
Sector
Revenue growth
8.38%
3.36%
Earnings growth
76.77%
14.79%
Revenue (5-year growth)
8.4%
6.26%
Earnings forecast
$1.83
-$0.20
Profitability
CVS
Sector
Profitability FY 2025
$55.4B
$2.6M
Return on invested capital
1.1%
-33.31%
Return on assets
0.67%
-29.46%
Return on equity
2.28%
-40.29%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
May
6
Estimated Next Earnings Date
May
12
Balance Sheet
CVS
Sector
Total cash
$10.7B
$25.7M
Short term investments
$2.4B
$22.7M
Total assets
$261.1B
$70.2M
Long term debt
$78.2B
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
40
Is NVDA Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 34x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 33x
Sell
26
Is GOOGL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 25x
Alerts
Buy
81
AGX alert for Mar 28
Argan, Inc. [AGX] is up 37.86% over the past day.
Sell
46
GDXU alert for Mar 28
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 12.26% over the past day.
Buy
51
GDXD alert for Mar 28
MicroSectors Gold Miners -3X Inverse Leveraged ETN [GDXD] is down 12.46% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
